CIK: 1716268 - Address: C/o Uniqure N.V., Paasheuvelweg 25A, Amsterdam, P7 11058BP
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/17/24 19:19
6/13/24
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7DS-185.120-4-744D
6/20/23 17:20
6/16/23
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7DS.d-6118.880-3-648D
3/1/23 16:09
2/27/23
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7DS.m-4120.790-2-442D
3/2/22 16:41
2/28/22
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7DS-2716.700-2-435D
1/28/22 17:08
1/26/22
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7DS-4318.120-2-635D
9/22/21 09:32
9/21/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7DS-16536.610-5-1138D
3/4/21 14:23
3/2/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7DS-4836.980-1-342D
1/28/21 10:49
1/26/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7DOChief MeS-2439.090-1-141D
9/22/20 09:48
9/21/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7DOChief MeS-17039.120-4-942D
6/24/20 16:21
6/23/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7DOChief MeS.d-1,88170.000-27-3746D
1/29/20 18:02
1/27/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7OChief MeS.m-45160.180-7-2128D
9/20/19 14:00
9/19/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsGut RobertP7OChief MeS-22547.160-5-1235D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact